Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Express Scripts
Moodys
Mallinckrodt
Dow

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR ASPIRIN AND DIPYRIDAMOLE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Aspirin And Dipyridamole

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000463 ↗ Post Coronary Artery Bypass Graft (CABG) Study Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1987-04-01 To determine the relative effectiveness of moderate versus more aggressive lipid lowering, and of low dose anticoagulation versus placebo, in delaying saphenous vein coronary bypass graft atherosclerosis and preventing occlusion of saphenous grafts of patients with saphenous vein coronary bypass grafts placed 1 to 11 years previously.
NCT00000496 ↗ Platelet Drug Trial in Coronary Disease Progression Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1979-12-01 To determine the effectiveness of the platelet inhibitor drugs dipyridamole and aspirin in reducing the angiographic progression of coronary artery disease over a five-year period and to test the predictive value of the platelet survival half-life in identifying patients with more rapid progression of coronary disease and development of its complications.
NCT00000510 ↗ Platelet-Inhibitor Drug Trial in Coronary Angioplasty Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1983-09-01 To determine the effectiveness of dipyridamole and aspirin in prevention of restenosis of the dilated lesion in patients who had undergone percutaneous transluminal coronary angioplasty (PTCA). Secondary aims were to determine the effectiveness of platelet inhibitor therapy in reducing the incidence of coronary events and the severity and incidence of angina.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Aspirin And Dipyridamole

Condition Name

Condition Name for Aspirin And Dipyridamole
Intervention Trials
Cardiovascular Diseases 4
Heart Diseases 4
Stroke 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Aspirin And Dipyridamole
Intervention Trials
Cardiovascular Diseases 5
Myocardial Ischemia 4
Ischemia 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Aspirin And Dipyridamole

Trials by Country

Trials by Country for Aspirin And Dipyridamole
Location Trials
United States 57
Canada 9
Italy 5
Australia 4
China 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Aspirin And Dipyridamole
Location Trials
Tennessee 3
Oklahoma 2
Minnesota 2
New Jersey 2
New York 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Aspirin And Dipyridamole

Clinical Trial Phase

Clinical Trial Phase for Aspirin And Dipyridamole
Clinical Trial Phase Trials
Phase 4 8
Phase 3 9
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Aspirin And Dipyridamole
Clinical Trial Phase Trials
Completed 17
Recruiting 3
Terminated 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Aspirin And Dipyridamole

Sponsor Name

Sponsor Name for Aspirin And Dipyridamole
Sponsor Trials
Boehringer Ingelheim 6
National Heart, Lung, and Blood Institute (NHLBI) 4
Yangzhou University 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Aspirin And Dipyridamole
Sponsor Trials
Other 40
Industry 8
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Harvard Business School
Dow
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.